Skip to content

Viking Therapeutics

US · VKTX #2352 by market cap Listed 2015
28.54 +0.16 +0.56%
Live - 5344 symbols - heartbeat 135s ago · 2026-10-08 07:00
Pre-market 28.50 -0.14%
After-hours 28.62 +0.29%
Overnight 28.41 -0.46%
Market cap
3.59B
P/B
8.78
EPS
-3.19
Reader sentiment Are you bullish or bearish on VKTX?

Anonymous reader poll. Unscientific, not investment advice.

Shares of Viking Therapeutics closed at 28.54, up 0.56%. That leaves the company valued at approximately 3.59B, the #2352 most valuable US-listed company we track. Across 16 analysts the consensus rating is Buy, with an average price target of 90.47 (+217%). Over the past year the stock has ranged from 25.77 to 43.15; it now sits 16% up that band.

✦ StockVane Quant Insights how this is computed

Quant Rating D Sell
  • Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
  • Signal has read SELL for 1 week.
  • Its last 4 Sell calls were followed by a 8% average decline over the next quarter.
See the full rating history & follow-along return →
Quant Sentiment Neutral
  • Recent price momentum is -20.9% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

42.1327.7528.542026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -12.45%
1M -18.15%
3M -32.26%
6M -15.31%
YTD -18.87%
1Y -9.50%
3Y +143.31%
5Y +368.64%

Key statistics

Price & volume

Prev close
28.38
Open
28.39
Day range
28.12 - 29.06
Avg price
28.62
Volume
5.41M
Turnover
154.81M
Amplitude
3.31%
52-week range
25.77 - 43.15

Valuation

P/E
-8.95
P/E (TTM)
-6.11
P/B
8.78
EPS
-3.19
Net profit
-400.95M
Net assets
408.36M

Share structure

Market cap
3.59B
Float cap
3.50B
Shares out
125.69M
Float shares
122.77M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2015-04-29
52-week range 16% of range
25.77 43.15

33.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-823.96K net over the window

Short interest

Shares short
22.58M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Viking Therapeutics (VKTX)?

Viking Therapeutics last traded at 28.54. The quote on this page refreshes every few seconds while US markets are open.

What is Viking Therapeutics's market cap?

About 3.59B.

What is the P/E ratio of Viking Therapeutics?

The trailing twelve-month P/E is -6.11. The Valuation tab shows it against the stock's own five-year range.

Does Viking Therapeutics pay a dividend?

Viking Therapeutics does not currently pay a regular dividend.

Is Viking Therapeutics a buy according to analysts?

The consensus of 16 analysts is a Buy rating, with an average 12-month price target of 90.47, which implies 217.0% upside from the current price. This is not investment advice.

What is Viking Therapeutics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Viking Therapeutics a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-10-08 07:00:13 · For reference only, not investment advice and not tailored to your situation.